MedTrace Logo

Bupivacaine Versus Lidocaine Infiltration for Postoperative Pain in Thyroid Surgery

NCT04427904 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2023-11-28

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of Bupivicaine and Lidocaine for postoperative pain control in thyroid surgery.

Conditions

  • Postoperative Pain
  • Thyroid Diseases
  • Anesthesia, Local

Interventions

DRUG

Bupivacaine 0.5% with 1:200 000 epinephrine

Bupivacaine 0.5% with 1:200 000 epinephrine. Total volume 10mL for local infiltration before neck incision.

DRUG

Lidocaine 2% with 1:100 000 epinephrine

Lidocaine 2% with 1:100 000 epinephrine. Total volume 10mL for local infiltration before neck incision.

Sponsors & Collaborators

  • St. Joseph's Healthcare Hamilton

    lead OTHER

Principal Investigators

  • Han Zhang, MD FRCSC · St. Joseph's Hospital Hamilton

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04427904 on ClinicalTrials.gov